BDNF and full-length and truncated TrkB expression in Alzheimer disease. Implications in therapeutic strategies.

Ferrer, I; Marín, C; Rey, M J; Ribalta, T; Goutan, E; Blanco, R; Tolosa, E; Martí, E

Ferrer, I; Marín, C; Rey, M J; Ribalta, T; Goutan, E; Blanco, R; Tolosa, E; Martí, E.

Affiliation

Ferrer I; Unitat de Neuropatologia, Servei d'Anatomía Patològica, Hospital Princeps d'Espanya (Hospital Bellvitge), Barcelona, Spain.

J Neuropathol Exp Neurol ; 58(7): 729-39, 1999 Jul.

Article in En | MEDLINE | ID: mdl-10411343

Subject(s)

Alzheimer Disease/metabolism; Brain-Derived Neurotrophic Factor/metabolism; Receptor Protein-Tyrosine Kinases/metabolism; Receptors, Nerve Growth Factor/metabolism; Aged; Aged, 80 and over; Alzheimer Disease/therapy; Female; Frontal Lobe/metabolism; Hippocampus/metabolism; Histological Techniques; Humans; Male; Peptide Fragments/metabolism; Postmortem Changes; Receptor Protein-Tyrosine Kinases/chemistry; Receptor, Ciliary Neurotrophic Factor; Receptors, Nerve Growth Factor/chemistry

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Receptors, Nerve Growth Factor / Receptor Protein-Tyrosine Kinases / Brain-Derived Neurotrophic Factor / Alzheimer Disease Limits: Aged / Aged80 / Female / Humans / Male Language: En Journal: J Neuropathol Exp Neurol Year: 1999 Document type: Article Affiliation country: Spain Country of publication: United kingdom

Search on Google

Add to My VHL

XML

PubMed Links